186 related articles for article (PubMed ID: 15778580)
41. Sensitivity analysis of the relative biological effectiveness predicted by the local effect model.
Friedrich T; Grün R; Scholz U; Elsässer T; Durante M; Scholz M
Phys Med Biol; 2013 Oct; 58(19):6827-49. PubMed ID: 24025596
[TBL] [Abstract][Full Text] [Related]
42. MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.
Wessels BW; Konijnenberg MW; Dale RG; Breitz HB; Cremonesi M; Meredith RF; Green AJ; Bouchet LG; Brill AB; Bolch WE; Sgouros G; Thomas SR
J Nucl Med; 2008 Nov; 49(11):1884-99. PubMed ID: 18927342
[TBL] [Abstract][Full Text] [Related]
43. 21 years of biologically effective dose.
Fowler JF
Br J Radiol; 2010 Jul; 83(991):554-68. PubMed ID: 20603408
[TBL] [Abstract][Full Text] [Related]
44. Basic principles of radiobiology, radiotherapy, and radiosurgery.
Shrieve DC; Klish M; Wendland MM; Watson GA
Neurosurg Clin N Am; 2004 Oct; 15(4):467-79, x. PubMed ID: 15450882
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic radionuclides: biophysical and radiobiologic principles.
Kassis AI
Semin Nucl Med; 2008 Sep; 38(5):358-66. PubMed ID: 18662557
[TBL] [Abstract][Full Text] [Related]
46. Isoeffect relationships for fractionated biologically targeted radiotherapy.
O'Donoghue JA
Radiother Oncol; 1990 Nov; 19(3):257-65. PubMed ID: 2281155
[TBL] [Abstract][Full Text] [Related]
47. Cellular Response to Exponentially Increasing and Decreasing Dose Rates: Implications for Treatment Planning in Targeted Radionuclide Therapy.
Solanki JH; Tritt T; Pasternack JB; Kim JJ; Leung CN; Domogauer JD; Colangelo NW; Narra VR; Howell RW
Radiat Res; 2017 Aug; 188(2):221-234. PubMed ID: 28541775
[TBL] [Abstract][Full Text] [Related]
48. BED-time charts and their application to the problems of interruptions in external beam radiotherapy treatments.
Sinclair JA; Oates JP; Dale RG
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):381-9. PubMed ID: 10760434
[TBL] [Abstract][Full Text] [Related]
49. Optimisation in radiotherapy I: defining the problem.
Ebert MA
Australas Phys Eng Sci Med; 1997 Sep; 20(3):164-76. PubMed ID: 9409017
[TBL] [Abstract][Full Text] [Related]
50. The time-dependent LQ model applied to the matching line of adjacent fields in radiotherapy.
Cederbaum M; Kuten A
Radiother Oncol; 1994 May; 31(2):181-3. PubMed ID: 8066198
[TBL] [Abstract][Full Text] [Related]
51. Targeted radionuclide therapy--an overview.
Dash A; Knapp FF; Pillai MR
Curr Radiopharm; 2013 Sep; 6(3):152-80. PubMed ID: 24059327
[TBL] [Abstract][Full Text] [Related]
52. Radiobiological indices that consider volume: a review.
Holloway L; Hoban P; Metcalfe P
Australas Phys Eng Sci Med; 2002 Jul; 25(2):47-57. PubMed ID: 12219845
[TBL] [Abstract][Full Text] [Related]
53. Problems and advances in the dosimetry of radionuclide targeted therapy.
Humm JL
Recent Results Cancer Res; 1996; 141():37-65. PubMed ID: 8722419
[No Abstract] [Full Text] [Related]
54. The evolution of practical radiobiological modelling.
Jones B; Dale RG
Br J Radiol; 2019 Jan; 92(1093):20180097. PubMed ID: 29557215
[TBL] [Abstract][Full Text] [Related]
55. Application of radiobiological dosimetry to radionuclide directed therapy.
Millar WT
Br J Cancer Suppl; 1990 Jul; 10():78-80. PubMed ID: 2383484
[TBL] [Abstract][Full Text] [Related]
56. [Influence of time-dose-relationships in therapeutic nuclear medicine applications on biological effectiveness of irradiation: consequences for dosimetry].
Oehme L; Dörr W; Wust P; Kotzerke J
Nuklearmedizin; 2008; 47(5):205-9. PubMed ID: 18852927
[TBL] [Abstract][Full Text] [Related]
57. Tumour therapy with radionuclides: assessment of progress and problems.
Carlsson J; Forssell Aronsson E; Hietala SO; Stigbrand T; Tennvall J
Radiother Oncol; 2003 Feb; 66(2):107-17. PubMed ID: 12648782
[TBL] [Abstract][Full Text] [Related]
58. Linear quadratic model and biologically equivalent dose for single fraction treatments.
Prasad SC
Med Dosim; 1992; 17(2):101-2. PubMed ID: 1616587
[TBL] [Abstract][Full Text] [Related]
59. Impact of radiobiological models on the calculation of the therapeutic parameters of Grid therapy for breast cancer.
Mahmoudi F; Chegeni N; Bagheri A; Fatahi Asl J; Batiar MT
Appl Radiat Isot; 2021 Aug; 174():109776. PubMed ID: 34082185
[TBL] [Abstract][Full Text] [Related]
60. Dose-rate effects in targeted radiotherapy.
Dale RG
Phys Med Biol; 1996 Oct; 41(10):1871-84. PubMed ID: 8912367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
